Arterial tortuosity syndrome in two Italian paediatric patients

BackgroundArterial tortuosity syndrome (ATS) (OMIM #208050) is a rare autosomal recessive connective tissue disorder characterized by tortuosity and elongation of the large and medium-sized arteries, propensity to aneurysms formation, vascular dissection, and pulmonary arteries stenosis. ATS is caused by mutations in SLC2A10 gene, encoding for the facilitative glucose transporter 10 (GLUT10). So far, 17 SLC2A10 mutations have been reported in 32 families, two of which were Italian with a total of five patients. Here we present the clinical and molecular characterization of two novel Italian paediatric ATS patients.MethodsThe exons and intronic flanking regions of SLC2A10 gene were amplified and direct sequencing was performed.ResultsIn both patients, the involvement of major- and medium-sized arteries was characteristic; the nonvascular connective tissue manifestations were mild and not pathognomic of the disorder. Both patients, born from non-consanguineous parents, were heterozygous for two different SLC2A10 mutations, three of which were recurrent and one was novel (p.Arg231Trp). This mutation is localized at the endofacial loop between the transmembrane domains 6 and 7 of GLUT10.ConclusionTwo novel ATS patients were characterized at clinical and molecular level. Overall, four ATS unrelated families are known in Italy so far. Though ATS clinical delineation improved in the last years, further works in the comprehension of disease presentation and complications onset, particularly in paediatric age, and on ATS molecular basis are needed to add new insights for diagnosis and prevention strategies for related complications.

[1]  A. Beuren,et al.  Dysplasia of the Systemic and Pulmonary Arterial System with Tortuosity and Lengthening of the Arteries: A New Entity, Diagnosed During Life, and Leading to Coronary Death in Early Childhood , 1969, Circulation.

[2]  N. Zoppi,et al.  Two novel SLC2A10/GLUT10 mutations in a patient with arterial tortuosity syndrome , 2007, American Journal of Medical Genetics. Part A.

[3]  G. Santoro,et al.  Hybrid approach in a case of arterial tortuosity syndrome. , 2008, Interactive cardiovascular and thoracic surgery.

[4]  H. Dietz,et al.  Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome , 2006, Nature Genetics.

[5]  L. Tsui,et al.  Identification of a p.Ser81Arg encoding mutation in SLC2A10 gene of arterial tortuosity syndrome patients from 10 Qatari families , 2008, Clinical genetics.

[6]  M. Muiesan,et al.  Exclusion of candidate genes in a family with arterial tortuosity syndrome , 2004, American journal of medical genetics. Part A.

[7]  C. Catsman-Berrevoets,et al.  Three new families with arterial tortuosity syndrome , 2004, American journal of medical genetics. Part A.

[8]  L. Tsui,et al.  A novel missense and a recurrent mutation in SLC2A10 gene of patients affected with arterial tortuosity syndrome. , 2009, Atherosclerosis.

[9]  E. Haan,et al.  Clinicopathologic findings in congenital aneurysms of the great vessels. , 1996, American journal of medical genetics.

[10]  A. De Paepe,et al.  Homozygosity mapping of a gene for arterial tortuosity syndrome to chromosome 20q13 , 2003, Journal of medical genetics.

[11]  B. Pletcher,et al.  Four sibs with arterial tortuosity: description and review of the literature. , 1996, American journal of medical genetics.

[12]  S. Nik-Zainal,et al.  Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families , 2008, Human mutation.

[13]  A. Teebi,et al.  A novel non-sense mutation in the SLC2A10 gene of an arterial tortuosity syndrome patient of Kurdish origin , 2009, European Journal of Pediatrics.